Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Strokes
Trial Information
Stroke: Insulin resistance intervention after stroke (IRIS). Volunteers needed for stroke prevention research study.
Researchers with the Department of Neurology in the University
of Kentucky College of Medicine are conducting a study to determine
whether pioglitazone (Actos®), a medicine approved to treat
diabetes mellitus, will prevent a second stroke or heart attack by
reversing hardening of the arteries (atherosclerosis) and
preventing blood vessel inflammation. This study will compare
pioglitazone to placebo (inactive substance) when added to current
medical practice for prevention of stroke and heart attack.
You may be eligible to participate in this study
if:
- You are a man or woman aged 45 years or older;
- You have had a stroke within the past 6 months;
- You have no history of diabetes mellitus; and
- You are willing to commit to a long-term research study of
stroke prevention that may last up to 5 years.
For more information,
Dr. Creed Pettigrew or Deborah Taylor
University of Kentucky Chandler Medical Center
740 South Limestone Street
Lexington, KY
Phone: 859-257-5560
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
